Valuation: Novartis AG

Market Cap 302B 259B 242B 221B 418B 28,934B 422B 2,867B 1,115B 14,529B 1,135B 1,110B 48,070B P/E 2026 *
22.6x
P/E 2027 * 19.3x
Enterprise Value 335B 287B 268B 245B 463B 32,063B 468B 3,177B 1,235B 16,100B 1,257B 1,230B 53,269B EV / Sales 2026 *
5.81x
EV / Sales 2027 * 5.38x
Free-Float
91.66%
Yield 2026 *
2.75%
Yield 2027 * 2.87%
1 day-0.50%
1 week+2.72%
Current month+0.13%
1 month-0.11%
3 months+7.02%
6 months-2.19%
Current year+15.66%
1 week 123.16
Extreme 123.16
128.26
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 2018-01-31
Director of Finance/CFO - 2026-03-15
Compliance Officer 58 2025-04-13
Director TitleAgeSince
Director/Board Member 67 2014-12-31
Director/Board Member 69 2015-12-31
Director/Board Member 61 2015-12-31
Date Insider Type Main position Quantity % Market Cap.
2/17/26 Sell 30,743 0.0015%
2/10/26 Sell 7,500 0.0004%
2/9/26 Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-0.52%+2.72%+25.21%+41.06% 302B
-0.94%+5.22%+79.03%+127.17% 1,119B
+1.21%+4.39%+53.51%+65.90% 651B
+0.06%+5.99%+27.84%+80.96% 468B
-1.38%+4.02%+42.52%+42.38% 374B
-1.06%+4.76%+2.00%+12.65% 259B
+0.13%+5.20%+52.94%+71.92% 238B
-0.53%+2.34%-18.53%-53.66% 208B
+0.04%+5.39%+28.26%+91.81% 181B
-0.30%+4.19%+11.36%-22.58% 160B
Average -0.36%+5.13%+30.41%+45.76% 395.98B
Weighted average by Cap. -0.35%+5.37%+44.45%+69.09%

Financials

2026 *2027 *
Net sales 57.65B 49.41B 46.22B 42.26B 79.74B 5,520B 80.59B 547B 213B 2,772B 216B 212B 9,171B 61.31B 52.54B 49.15B 44.94B 84.8B 5,870B 85.7B 582B 226B 2,948B 230B 225B 9,753B
Net income 13.95B 11.96B 11.18B 10.23B 19.3B 1,336B 19.5B 132B 51.46B 671B 52.38B 51.25B 2,219B 15.5B 13.29B 12.43B 11.36B 21.44B 1,484B 21.67B 147B 57.18B 745B 58.2B 56.94B 2,466B
Net Debt 32.68B 28.01B 26.2B 23.95B 45.2B 3,129B 45.68B 310B 121B 1,571B 123B 120B 5,199B 27.82B 23.84B 22.3B 20.39B 38.48B 2,664B 38.89B 264B 103B 1,338B 104B 102B 4,425B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
26-08-24 CHF 126.76 -0.52% 1,658,623
26-08-21 CHF 127.42 +0.85% 2,706,020
26-08-20 CHF 126.34 -0.61% 1,856,746
26-08-19 CHF 127.12 +1.24% 2,053,740
26-08-18 CHF 125.56 +1.75% 1,794,769
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
158.98USD
Average target price
154.32USD
Spread / Average Target
-2.93%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock